Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wanda and Dignity Health to Launch Digital Health Platform

By HospiMedica International staff writers
Posted on 14 Mar 2016
Wanda (San Francisco, CA, USA) has signed a deal with a Dignity Health (San Francisco, CA, USA) to launch a digital health oncology care platform that will enable medical professionals to make informed oncological treatment decisions.

The OncoVerse digital healthcare platform will enable care teams to collaborate in real time, across all disciplines, in order to determine the most effective treatment plan for cancer patients. More...
The virtual care collaboration platform enables unprecedented information-sharing capabilities through geographically dispersed, structured collaboration of the multidisciplinary care team, expanding the reach of clinical decision-making support to rural and remote areas, thus enabling patients in those locations to benefit from insights previously only shared at large medical centers.

The digital healthcare platform also allows medical professionals to highlight cancer-related cases for evidence-based peer collaboration, review, treatment recommendations and second opinions that are available 24/7 from any computer or other web-enabled device. Wanda is a NetScientific (London, United Kingdom) portfolio company. NetScientific is a transatlantic biomedical and healthcare group that funds, develops, and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the USA and Europe with a primary focus on digital health, diagnostics and therapeutics.

“OncoVerse will streamline and support the decision making processes of Dignity Health's physicians and other supporting health care professionals by ensuring that the entire care team has the right information at the right time, which reinforces the power of personalized medicine,” said Steve Curd, CEO of Wanda. “As cancer therapies continue to advance, facilitating individualized cancer decision support is well-aligned with Wanda's mission: improving the efficiency and effectiveness of the management of chronic conditions.”

“Dignity Health is committed to developing partnerships that harness the tremendous potential of technology to help providers and patients make better day-to-day decisions about care,” said Costanzo DiPerna, MD, medical director for the Dignity Health Cancer Institute of the Greater Sacramento region and chief of thoracic surgery. “We are excited to work with Wanda and deliver on our vision to provide the highest quality patient care.”

OncoVerse was initially conceived by a Dignity Health physician who wanted a tool to improve team collaboration, especially when evaluating a complex cancer case and determining the appropriate treatment plan. Dignity Health engaged Wanda to develop the software due to the company's proven track record to support informed treatment decisions, and to reduce administrative costs. Wanda and Dignity Health intend to jointly market the Oncoverse platform to other oncology programs across the US later in 2016.

Related Links:

Wanda
Dignity Health
NetScientific



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.